Delivery Order SPE2DB22D1106-SPE2DB24FEAP9
- Not listed
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRELEGY ELLIPTA 100-62.5-25 60S, a specialty pharmaceutical product. The contract has a potential value of $3,138.17 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and will be delivering the pharmaceutical product from its corporate...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,068.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. This delivery order contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $2,961.48 contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a specialty pharmaceutical product. The award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00, which serves...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $2,168.04 to provide TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. This contract has a period of performance through February 28, 2024 and was awarded on February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRELEGY ELLIPTA 100-62.5-25 60S medication. The $7,259.43 contract has an ultimate completion date of March 29, 2024 and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, through its Corporate Office in Conshohocken, Pennsylvania, serves as the prime contractor for this award, which is part...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564147460 - TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The award, valued at $7,194.39, has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has a potential value of $6,767.40 and a performance period through January 29, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $3,736.05, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The delivery order has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,261,731 units of the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. The delivery order has a ceiling value of $4,463.85 and is set to be completed by April 15, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is a part of a larger indefinite delivery contract (IDC) with DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The $6,322.28 contract has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds a $999,999,999.00 indefinite delivery contract with DLA to provide a comprehensive range of pharmaceutical products and...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEAP9Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,681,115 units of the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The contract has a potential value of $56,238.08 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order, which does not have a set-aside designation. This award is issued under Amerisourcebergen's existing indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $56.2k | 2/15/24 |